(0.74%) 5 083.75 points
(0.56%) 38 284 points
(0.90%) 17 595 points
(0.77%) $79.61
(2.64%) $1.983
(0.08%) $2 312.80
(-0.63%) $26.58
(0.91%) $963.60
(0.09%) $0.934
(0.21%) $11.05
(-0.02%) $0.798
(-1.36%) $91.99
0.10% £ 1 922.00
Live Chart Being Loaded With Signals
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise...
Stats | |
---|---|
Объем за сегодня | 646 116 |
Средний объем | 929 131 |
Рыночная капитализация | 1.23B |
EPS | £0 ( 2023-09-06 ) |
Дата следующего отчета о доходах | ( £0 ) 2024-05-23 |
Last Dividend | £21.10 ( 2023-06-15 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.89 |
ATR14 | £9.82 (0.51%) |
Объем Корреляция
EMIS Group PLC Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
EMIS Group PLC Корреляция - Валюта/Сырье
EMIS Group PLC Финансовые показатели
Annual | 2022 |
Выручка: | £175.37M |
Валовая прибыль: | £162.47M (92.64 %) |
EPS: | £0.530 |
FY | 2022 |
Выручка: | £175.37M |
Валовая прибыль: | £162.47M (92.64 %) |
EPS: | £0.530 |
FY | 2021 |
Выручка: | £168.23M |
Валовая прибыль: | £151.97M (90.34 %) |
EPS: | £0.462 |
FY | 2020 |
Выручка: | £159.45M |
Валовая прибыль: | £139.12M (87.25 %) |
EPS: | £0.481 |
Financial Reports:
No articles found.
EMIS Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£17.60 (N/A) |
£0 (N/A) |
£21.10 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £5.60 | 2010-09-22 |
Last Dividend | £21.10 | 2023-06-15 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | £308.10 | -- |
Avg. Dividend % Per Year | 1.42% | -- |
Score | 4.57 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.22 | |
Div. Directional Score | 9.09 | -- |
Year | Amount | Yield |
---|---|---|
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £27.10 | 3.18% |
2019 | £29.80 | 3.24% |
2020 | £31.60 | 2.82% |
2021 | £33.60 | 3.03% |
2022 | £35.20 | 2.65% |
2023 | £21.10 | 1.13% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
STS.L | Dividend Knight | 2023-10-05 | Quarterly | 38 | 1.48% | |
JUST.L | Dividend Royal | 2023-08-24 | Annually | 11 | 93.97% | |
CCEP.L | Dividend Knight | 2023-05-11 | Annually | 6 | 1.61% | |
QQ.L | Dividend Knight | 2023-07-27 | Semi-Annually | 19 | 1.52% | |
GFTU.L | Dividend Knight | 2023-09-21 | Semi-Annually | 15 | 2.21% | |
ALFA.L | Dividend King | 2023-09-14 | Semi-Annually | 5 | 3.78% | |
TORO.L | Dividend King | 2023-08-10 | Quarterly | 9 | 8.28% | |
LWI.L | Dividend King | 2023-06-29 | Quarterly | 53 | 2.58% | |
CRDA.L | Dividend Knight | 2023-08-31 | Semi-Annually | 32 | 0.95% | |
RTC.L | Dividend Royal | 2023-08-03 | Annually | 27 | 157.11% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.189 | 1.500 | 6.22 | 9.33 | [0 - 0.5] |
returnOnAssetsTTM | 0.148 | 1.200 | 5.08 | 6.10 | [0 - 0.3] |
returnOnEquityTTM | 0.245 | 1.500 | 8.39 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.669 | -1.000 | 3.31 | -3.31 | [0 - 1] |
currentRatioTTM | 1.210 | 0.800 | 8.95 | 7.16 | [1 - 3] |
quickRatioTTM | 0.649 | 0.800 | -0.887 | -0.709 | [0.8 - 2.5] |
cashRatioTTM | 0.649 | 1.500 | 7.50 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0194 | -1.500 | 9.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.25 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0306 | -1.500 | 9.88 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.926 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.158 | 1.000 | 8.84 | 8.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.59 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.780 | 0.800 | 8.13 | 6.51 | [0.5 - 2] |
Total Score | 12.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.07 | 1.000 | 6.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.245 | 2.50 | 8.97 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.80 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.21 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.669 | 1.500 | 3.31 | -3.31 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.263 | 1.000 | 5.91 | 0 | [0.1 - 0.5] |
Total Score | 5.22 |
EMIS Group PLC
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа